MedTrace Logo

Vitamin B12 Supplementation in Diabetic Neuropathy

NCT04706377 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2021-01-12

No results posted yet for this study

Summary

This prospective double-blind placebo-controlled trial aims to investigate the safety and efficacy of oral dispersible tablet of vitamin B12 for 1 year, in 90 patients with diabetes mellitus type 2 and neuropathy.

Conditions

Interventions

DIETARY_SUPPLEMENT

B12 fix 1000mcg

oral dispersible tablet with vitamin B12 1000mcg

OTHER

Placebo

Placebo tablet

Sponsors & Collaborators

  • University of Sheffield

    collaborator OTHER

  • University Hospital Tuebingen

    collaborator OTHER

  • Aristotle University Of Thessaloniki

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2020-02-28
Completion
2020-02-28

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04706377 on ClinicalTrials.gov